NCT03154827 2024-09-05Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)BioLineRx, Ltd.Phase 1/2 Terminated1 enrolled 6 charts
NCT03922477 2022-02-21A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid LeukemiaHoffmann-La RochePhase 1 Terminated13 enrolled 12 charts